Ann Neurol. 2008 Dec;64 Suppl 2:S3-15.

What causes cell death in Parkinson's disease?

Source

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Abstract

Currently, there is no proven neuroprotective or neurorestorative therapy for Parkinson's disease (PD). Several advances in the genetics of PD have created an opportunity to develop mechanistic-based therapies that hold particular promise for identifying agents that slow and even halt the progression of PD, as well as restore function. Here we review many of the advances in the last decade regarding the identification of new targets for the treatment of PD based on understanding the molecular mechanisms of how mutations in genes linked to PD cause neurodegeneration.

PMID:: 19127586; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Parkinson's Disease - MedlinePlus Health Information

Supplemental Content

Related citations

Review Autosomal dominant Parkinson's disease and the route to new therapies. [Expert Rev Neurother. 2007]
Review Autosomal dominant Parkinson's disease and the route to new therapies.
Morris HR. Expert Rev Neurother. 2007 Jun; 7(6):649-56.
Review Parkinson's disease. [Hum Mol Genet. 2007]
Review Parkinson's disease.
Thomas B, Beal MF. Hum Mol Genet. 2007 Oct 15; 16 Spec No. 2:R183-94.
Review Genetics of Parkinson's disease. [Ann Med. 2005]
Review Genetics of Parkinson's disease.
Morris HR. Ann Med. 2005; 37(2):86-96.
Review Parkinson's disease: from monogenic forms to genetic susceptibility factors. [Hum Mol Genet. 2009]
Review Parkinson's disease: from monogenic forms to genetic susceptibility factors.
Lesage S, Brice A. Hum Mol Genet. 2009 Apr 15; 18(R1):R48-59.
Review Prospects for new restorative and neuroprotective treatments in Parkinson's disease. [Nature. 1999]
Review Prospects for new restorative and neuroprotective treatments in Parkinson's disease.
Dunnett SB, Björklund A. Nature. 1999 Jun 24; 399(6738 Suppl):A32-9.

See reviews... See all...

Cited by 9 PubMed Central articles

α-Synuclein expression selectively affects tumorigenesis in mice modeling Parkinson's disease. [PLoS One. 2011]
α-Synuclein expression selectively affects tumorigenesis in mice modeling Parkinson's disease.
Israeli E, Yakunin E, Zarbiv Y, Hacohen-Solovich A, Kisos H, Loeb V, Lichtenstein M, Ben-Gedalya T, Sabag O, Pikarsky E, et al. PLoS One. 2011; 6(5):e19622. Epub 2011 May 18.
Loss of nuclear activity of the FBXO7 protein in patients with parkinsonian-pyramidal syndrome (PARK15). [PLoS One. 2011]
Loss of nuclear activity of the FBXO7 protein in patients with parkinsonian-pyramidal syndrome (PARK15).
Zhao T, De Graaff E, Breedveld GJ, Loda A, Severijnen LA, Wouters CH, Verheijen FW, Dekker MC, Montagna P, Willemsen R, et al. PLoS One. 2011 Feb 11; 6(2):e16983. Epub 2011 Feb 11.
Review Astrocytes and therapeutics for Parkinson's disease. [Neurotherapeutics. 2010]
Review Astrocytes and therapeutics for Parkinson's disease.
Rappold PM, Tieu K. Neurotherapeutics. 2010 Oct; 7(4):413-23.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

What causes cell death in Parkinson's disease?
What causes cell death in Parkinson's disease?
Ann Neurol. 2008 Dec ;64 Suppl 2:S3-15.

PubMed
Zscan4 regulates telomere elongation and genomic stability in ES cells.
Zscan4 regulates telomere elongation and genomic stability in ES cells.
Nature. 2010 Apr 8 ;464(7290):858-63. Epub 2010 Mar 24 .

PubMed
Heparin-binding epidermal growth factor expression in KATO-III cells after Helic...
Heparin-binding epidermal growth factor expression in KATO-III cells after Helicobacter pylori stimulation under the influence of strychnos Nux vomica and Calendula officinalis.
Homeopathy. 2010 Jul ;99(3):177-82.

PubMed
PD-1 expression on human CD8 T cells depends on both state of differentiation an...
PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status.
AIDS. 2007 Oct 1 ;21(15):2005-13.

PubMed
Methane emissions from cattle.
Methane emissions from cattle.
J Anim Sci. 1995 Aug ;73(8):2483-92.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: